Delucemine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 3,3-bis(3-fluorophenyl)-N-methylpropan-1-amine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 186495-49-8 |
| ATC code | None |
| PubChem | CID 156421 |
| ChemSpider | 137745 |
| UNII | 124LSR3H2X |
| Chemical data | |
| Formula | C16H17F2N |
| Mol. mass | 261.3097 g/mol |
|
|
|
|
| |
|
Delucemine (NPS-1506) is a drug which acts as an NMDA antagonist and a serotonin reuptake inhibitor, and has neuroprotective effects. It was originally investigated for the treatment of stroke but is now being studied as a potential antidepressant. It is currently in clinical trials.[1]
S.T. Moe, D.L. Smith, K. By, J.A. Egan, C.N. Filer, J. Label. Comp. Radiopharm. 41, 535 (1998).
References [edit]
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |